Complications of hepatic artery infusion: A review of 4580 reported cases

International Journal of Gastrointestinal Cancer

Volumn 30, Issue 3, 2001, Pages 147-160

  Barnett, Kevin T ^a   Malafa, Mokenge P ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colorectal cancer; Hepatic artery infusion; Liver metastases

Indexed keywords

ANTINEOPLASTIC AGENT; FLOXURIDINE; FLUOROURACIL;

ABDOMINAL PAIN; ARTERY CATHETERIZATION; ARTERY OCCLUSION; BILE DUCT INJURY; BILIARY TRACT DISEASE; BLOOD VESSEL INJURY; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; COLORECTAL CANCER; DIARRHEA; DRUG INFUSION; FALSE ANEURYSM; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEMATOMA; HEPATIC ARTERY; HUMAN; IATROGENIC DISEASE; IMPLANT; INFUSION PUMP; INTIMA; LIVER ABSCESS; LIVER METASTASIS; MAJOR CLINICAL STUDY; MORTALITY; MUCOSA INFLAMMATION; NAUSEA; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCLEROSING CHOLANGITIS; SEPSIS; SEROMA; SKIN NECROSIS; STOMATITIS; THROMBOSIS; TOXIC HEPATITIS; VOMITING; WOUND INFECTION;

EID: 0035785519     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: 10.1385/ijgc:30:3:147     Document Type: Review

References (125)

1. Brennan MJ, Talley RJ, Drake EH, et al. 5-Fluorouracil treatment of liver metastases by continuous hepatic artery infusion via Cournand catheter. Ann Surg 1963;158:405-419
2. Sullivan RD, Norcross JW, Watkins E. Chemotherapy of Metastatic Liver Cancer by Prolonged Hepatic-Artery Infusion. N Engl J Med 1964;270:321-327.
3. Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999;341:2039-2048.
4. Allen-Mersh TG, Earlam S, Fordy C, et al. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994;344:1255-1260.
5. Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer Statistics, 2001. CA Cancer J Clin 2001;51:15-36.
6. Weiss L, Grundmann E, Torhorst J, et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 1986;150:195-203.
7. Ackerman NB. The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery 1974;75:589-596.
8. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. Meta-analysis Group In Cancer. J Clin Oncol 1998;16:301-308.
9. Lokich JJ, Ahlgren JD, Gullo JJ, et al. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study. J Clin Oncol 1989;7:425-432.
10. Seifert P, Baker LH, Reed ML, et al. Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma. Cancer 1975;36:123-128.
11. Ensminger WD, Rosowsky A, Raso V, et al. A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2′-deoxyuridine and 5-fluorouracil. Cancer Res 1978;38:3784-3792.
12. Ansfield FJ, Ramirez G, Davis HL, Jr., et al. Further clinical studies with intrahepatic arterial infusion with 5- fluorouracil. Cancer 1975;36:2413-2417.
13. Burrows JH, Talley RW, Drake EH, et al. Infusion of fluorinated pyrimidines into hepatic artery for treatment of metastatic carcinoma of liver. Cancer 1967;20:1886-1892.
14. Reed ML, Vaitkevicius VK, Al-Sarraf M, et al. The practicality of chronic hepatic artery infusion therapy of primary and metastatic hepatic malignancies: ten-year results of 124 patients in a prospective protocol. Cancer 1981;47:402-409.
15. Watkins E, Jr., Khazei AM, Nahra KS. Surgical basis for arterial infusion chemotherapy of disseminated carcinoma of the liver. Surg Gynecol Obstet 1970;130:581-605.
16. Stagg RJ, Lewis BJ, Friedman MA, et al. Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver. Ann Intern Med 1984;100:736-743.
17. Buchwald H, Grage TB, Vassilopoulos PP, et al. Intraarterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump. Cancer 1980;45:866-869.
18. Daly JM, Kemeny N, Oderman P, et al. Long-term hepatic arterial infusion chemotherapy. Anatomic considerations, operative technique, and treatment morbidity. Arch Surg 1984;119:936-941.
19. Fong Y. Surgical therapy of hepatic colorectal metastasis. CA Cancer J Clin 1999;49:231-255.
20. Vauthey JN, Marsh R, Cendan JC, et al. Arterial therapy of hepatic colorectal metastases. Br J Surg 1996;83:447-455.
21. Akasu T, Moriya Y, Takayama T. A pilot study of multimodality therapy for initially unresectable liver metastases from colorectal carcinoma: hepatic resection after hepatic arterial infusion chemotherapy and portal embolization. Jpn J Clin Oncol 1997;27:331-335.
22. Allen-Mersh TG, Glover C, Fordy C, et al. Randomized trial of regional plus systemic fluorinated pyrimidine compared with systemic fluorinated pyrimidine in treatment of colorectal liver metastases. Eur J Surg Oncol 2000;26:468-473.
23. Ambiru S, Miyazaki M, Ito H, et al. Adjuvant regional chemotherapy after hepatic resection for colorectal metastases. Br J Surg 1999;86:1025-1031.
24. Anderson JH, Kerr DJ, Cooke TG, et al. A phase I study of regional 5-fluorouracil and systemic folinic acid for patients with colorectal liver metastases. Br J Cancer 1992;65:913-915.
25. Arai Y, Inaba Y, Takeuchi Y, et al. Intermittent hepatic arterial infusion of high-dose 5FU on a weekly schedule for liver metastases from colorectal cancer. Cancer Chemother Pharmacol 1997;40:526-530.
26. Arai Y. Interventional radiology for hepatic arterial infusion chemotherapy. Gan To Kagaku Ryoho 1996;23:1385-1389.
27. Arai Y, Endo T, Sone Y, et al. Management of patients with unresectable liver metastases from colorectal and gastric cancer employing an implantable port system. Cancer Chemother Pharmacol 1992;31:S99-S102.
28. Balch CM, Urist MM, McGregor ML. Continuous regional chemotherapy for metastatic colorectal cancer using a totally implantable infusion pump. A feasibility study in 50 patients. Am J Surg 1983;145:285-290.
29. Barone RM, Byfield JE, Goldfarb PB, et al. Intra-arterial chemotherapy using an implantable infusion pump and liver irradiation for the treatment of hepatic metastases. Cancer 1982;50:850-862.
30. Berlin J, Merrick HW, Smith TJ, et al. Phase II evaluation of treatment of complete resection of hepatic metastases from colorectal cancer and adjuvant hepatic arterial infusion of floxuridine: an Eastern Cooperative Oncology Group Study (PB083). Am J Clin Oncol 1999;22:291-293.
31. Bertuccelli M, Falcone A, Campoccia S, et al. Intrahepatic chemotherapy with floxuridine, leucovorin and dexamethasone in continuous infusion and mitomycin-C bolus in unresectable hepatic metastases from colorectal cancer: a phase II study. Tumori 1999;85:473-477.
32. Borner M, Laffer U, Ludwig C, et al. Effectiveness and low toxicity of hepatic artery infusion with fluorouracil and mitomycin for metastatic colorectal cancer confined to the liver. The Swiss Group for Clinical and Epidemiological Cancer Research (SAKK). Ann Oncol 1990;1:227-228.
33. Boyle FM, Smith RC, Levi JA. Continuous hepatic artery infusion of 5-fluorouracil for metastatic colorectal cancer localised to the liver. Aust N Z J Med 1993;23:32-34.
34. Buroker T, Samson M, Correa J, et al. Hepatic artery infusion of 5-FUDR after prior systemic 5-fluorouracil. Cancer Treat Rep 1976;60:1277-1279.
35. Cady B, Oberfield RA. Regional infusion chemotherapy of hepatic metastases from carcinoma of the colon. Am J Surg 1974;127:220-227.
36. Chang AE, Schneider PD, Sugarbaker PH, et al. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987;206:685-693.
37. Cohen AM, Kaufman SD, Wood WC. Treatment of colorectal cancer hepatic metastases by hepatic artery chemotherapy. Dis Colon Rectum 1985;28:389-393.
38. Cohen AM, Schaeffer N, Higgins J. Treatment of metastatic colorectal cancer with hepatic artery combination chemotherapy. Cancer 1986;57:1115-1117.
39. Cortesi E, Capussotti L, Di Tora P, et al. Bolus vs. continuous hepatic arterial infusion of cisplatin plus intravenous 5-fluorouracil chemotherapy for unresectable colorectal metastases. Dis Colon Rectum 1994;37:S138-S143.
40. Curley SA, Chase JL, Roh MS, et al. Technical considerations and complications associated with the placement of 180 implantable hepatic arterial infusion devices. Surgery 1993;114:928-935.
41. Curley SA, Roh MS, Chase JL, et al. Adjuvant hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases. Am J Surg 1993;166:743-746; discussion 746-748.
42. Daly JM, Kemeny N, Sigurdson E, et al. Regional infusion for colorectal hepatic metastases. A randomized trial comparing the hepatic artery with the portal vein. Arch Surg 1987;122:1273-1277.
43. Davidson BS, Izzo F, Chase JL, et al. Alternating floxuridine and 5-fluorouracil hepatic arterial chemotherapy for colorectal liver metastases minimizes biliary toxicity. Am J Surg 1996;172:244-247.
44. Dazzi C, Fiorentini G, Davitti B, et al. High-dose intraarterial plus intraperitoneal chemotherapy combined with hemofiltration in liver metastases from colorectal cancer. Tumori 1994;80:204-208.
45. Donegan WL. Hepatic artery infusion chemotherapy for colorectal metastases: a personal experience. J Surg Oncol 1985;30:177-183.
46. Earlam S, Glover C, Davies M, et al. Effect of regional and systemic fluorinated pyrimidine chemotherapy on quality of life in colorectal liver metastasis patients. J Clin Oncol 1997;15:2022-2029.
47. Focan C, Levi F, Kreutz F, et al. Continuous delivery of venous 5-fluorouracil and arterial 5-fluorodeoxyuridine for hepatic metastases from colorectal cancer: feasibility and tolerance in a randomized phase II trial comparing flat versus chronomodulated infusion. Anticancer Drugs 1999;10:385-392.
48. Fortuny IE, Theologides A, Kennedy BJ. Hepatic arterial infusion for liver metastases from colon cancer: comparison of mitomycin C(NSC-26980) and 5-fluorouracil (NSC-19893). Cancer Chemother Rep 1975;59:401-404.
49. Goey SH, Eggermont AM, Oskam R, et al. Prolonged continuous hepatic artery infusion with interleukin-2 in unresectable liver metastases of colorectal cancer: a phase IA-B study. Ann Oncol 1996;7:317-319.
50. Grage TB, Vassilopoulos PP, Shingleton WW, et al. Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: A Central Oncology Group study. Surgery 1979;86:550-555.
51. Habbe TG, McCowan TC, Goertzen TC, et al. Complications and technical limitations of hepatic arterial infusion catheter placement for chemotherapy. J Vasc Interv Radiol 1998;9:233-239.
52. Hanazaki K, Kawamura N, Sodeyama H, et al. Carcinoembryonic antigen and intra-arterial chemotherapy response of liver metastases. Hepatogastroenterology 1998;45:462-467.
53. Herbsman H, Hassan A, Gardner B, et al. Treatment of hepatic metastases with a combination of hepatic artery infusion chemotherapy and external radiotherapy. Surg Gynecol Obstet 1978;147:13-17.
54. Hidalgo OF, Rebollo J, Vieitez JM, et al. Intraarterial hepatic treatment with carboplatin (CBDCA) and 5- fluorouracil (5-FU) in metastases from colorectal carcinoma. Am J Clin Oncol 1993;16:30-33.
55. Hohenberger P, Schlag P, Herrmann R, et al. Intrahepatic 5-FU retreatment of liver metastases of colorectal cancer that were progressive under previous systemic chemotherapy. Am J Clin Oncol 1989;12:447-452.
56. Hohn DC, Stagg RJ, Friedman MA, et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol 1989;7:1646-1654.
57. Hohn DC, Rayner AA, Economou JS, et al. Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion. Cancer 1986;57:465-470.
58. Hohn DC, Stagg RJ, Price DC, et al. Avoidance of gastroduodenal toxicity in patients receiving hepatic arterial 5-fluoro-2′-deoxyuridine. J Clin Oncol 1985;3:1257-1260.
59. Howell JD, Warren HW, Anderson JH, et al. Intra-arterial 5-fluorouracil and intravenous folinic acid in the treatment of liver metastases from colorectal cancer. Eur J Surg 1999;165:652-658.
60. Howell JD, McArdle CS, Kerr DJ, et al. A phase II study of regional 2-weekly 5-fluorouracil infusion with intravenous folinic acid in the treatment of colorectal liver metastases. Br J Cancer 1997;76:1390-1393.
61. Hunt TM, Flowerdew AD, Birch SJ, et al. Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases. Br J Surg 1990;77:779-782.
62. Johnson LP, Rivkin SE. The implanted pump in metastatic colorectal cancer of the liver. Risk versus benefit. Am J Surg 1985;149:595-598.
63. Kemeny N, Seiter K, Conti JA, et al. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update. Cancer 1994;73:1134-1142.
64. Kemeny N, Conti JA, Sigurdson E, et al. A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases. Cancer 1993;71:1964-1971.
65. Kemeny N, Seiter K, Niedzwiecki D, et al. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer 1992;69:327-334.
66. Kemeny N, Daly J, Reichman B, et al. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med 1987;107:459-65.
67. Kemeny N, Daly J, Oderman P, et al. Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma. J Clin Oncol 1984;2:595-600.
68. Kerr DJ, Ledermann JA, McArdle CS, et al. Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracil. J Clin Oncol 1995;13:2968-2972.
69. Knol JA, Walker SC, Robertson JM, et al. Incorporation of 5-bromo-2′-deoxyuridine into colorectal liver metastases and liver in patients receiving a 7-day hepatic arterial infusion. Cancer Res 1995;55:3687-3691.
70. Kusunoki M, Yanagi H, Noda M, et al. Results of pharmacokinetic modulating chemotherapy in combination with hepatic arterial 5-fluorouracil infusion and oral UFT after resection of hepatic colorectal metastases. Cancer 2000;89:1228-1235.
71. Link KH, Kornmann M, Leder G, et al. Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C. Gan To Kagaku Ryoho 1999;26:269-281.
72. Lokich JJ. Hepatic artery chemotherapy: the relative importance of direct organ distribution vs. the constant-infusion schedule. Am J Clin Oncol 1984;7:125-128.
73. Lorenz M, Muller HH. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol 2000;18:243-254.
74. Lorenz M, Muller HH, Schramm H, et al. Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann Surg 1998;228:756-762.
75. Lorenz M, Staib-Sebler E, Koch B, et al. The value of postoperative hepatic arterial infusion following curative liver resection. Anticancer Res 1997;17:3825-3833.
76. Lorenz M, Hottenrott C, Maier P, et al. Continuous regional treatment with fluoropyrimidines for metastases from colorectal carcinomas: influence of modulation with leucovorin. Semin Oncol 1992;19:163-170.
77. Lygidakis NJ, Ziras N, Parissis J. Resection versus resection combined with adjuvant pre- and post-operative chemotherapy - immunotherapy for metastatic colorectal liver cancer. A new look at an old problem. Hepatogastroenterology 1995;42:155-161.
78. Marinelli A, de Brauw LM, Beerman H, et al. Isolated liver perfusion with mitomycin C in the treatment of colorectal cancer metastases confined to the liver. Jpn J Clin Oncol 1996;26:341-350.
79. Martin JK, Jr., O'Connell MJ, Wieand HS, et al. Intraarterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg 1990;125:1022-1027.
80. McCracken JD, Weatherall TJ, Oishi N, et al. Adjuvant intrahepatic chemotherapy with mitomycin and 5-FU combined with hepatic irradiation in high-risk patients with carcinoma of the colon: a Southwest Oncology Group phase II pilot study. Cancer Treat Rep 1985;69:129-131.
81. Miller RL, Bukowski RM, Andresen S, et al. Phase II evaluation of sequential hepatic artery infusion of 5-fluorouracil and hepatic irradiation in metastatic colorectal carcinoma. J Surg Oncol 1988;37:1-4.
82. Niederhuber JE, Ensminger W, Gyves J, et al. Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer 1984;53:1336-1343.
83. Oberfield RA, McCaffrey JA, Polio J, et al. Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary. Cancer 1979;44:414-423.
84. Ogata Y, Shirouzu K, Akagi Y, et al. Hepatic arterial chemotherapy for liver metastases from colorectal cancer. Kurume Med J 1996;43:41-47.
85. Okuno K, Shigeoka H, Lee YS, et al. Adjuvant hepatic arterial IL-2 and MMC, 5-FU after curative resection of colorectal liver metastases. Hepatogastroenterology 1996;43:688-691.
86. Okuno K, Hirohata T, Nakamura K, et al. Hepatic arterial infusions of interleukin-2-based immunochemotherapy in the treatment of unresectable liver metastases from colorectal cancer. Clin Ther 1993;15:672-683.
87. Patt YZ, Hoque A, Lozano R, et al. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin. J Clin Oncol 1997;15:1432-1438.
88. Patt YZ, Boddie AW, Jr., Charnsangavej C, et al. Hepatic arterial infusion with floxuridine and cisplatin: overriding importance of antitumor effect versus degree of tumor burden as determinants of survival among patients with colorectal cancer. J Clin Oncol 1986;4:1356-1364.
89. Patt YZ, Chuang VP, Wallace S, et al. The palliative role of hepatic arterial infusion and arterial occlusion in colorectal carcinoma metastatic to the liver. Lancet 1981;1:349-350.
90. Ramming KP, O'Toole K. The use of the implantable chemoinfusion pump in the treatment of hepatic metastases of colorectal cancer. Arch Surg 1986;121:1440-1444.
91. Ramming KP, Sparks FC, Eilber FR, et al. Hepatic artery ligation and 5-fluorouracil infusion for metastatic colon carcinoma and primary hepatoma. Am J Surg 1976;132:236-242.
92. Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 1992;10:1112-1118.
93. Rougier P, Ducreux M, Pignon JP, et al. Prognostic factors in patients with liver metastases from colorectal carcinoma treated with discontinuous intra-arterial hepatic chemotherapy. Eur J Cancer 1991;27:1226-1230.
94. Rougier P, Munck JN, Elias D, et al. Intra-arterial hepatic chemotherapy with pirarubicin. Preclinical and clinical studies. Am J Clin Oncol 199013:S1-S4.
95. Rougier P, Lasser P, Elias D, et al. Intra-arterial hepatic chemotherapy for metastatic liver from colo- rectal carcinoma origin. Sel Cancer Ther 1989;5:47-54.
96. Rubin JT, Lotze MT, Rosenfelder D, et al. Treatment of hepatic-metastatic colorectal cancer with a chemotherapeutic emulsion: interim results of a phase I trial. Ann Surg Oncol 1995;2:351-359.
97. Rudroff C, Altendorf-Hoffmann A, Stangl R, et al. Prospective randomised trial on adjuvant hepatic-artery infusion chemotherapy after R0 resection of colorectal liver metastases. Langenbecks Arch Surg 1999;384:243-249.
98. Rustin RB, Vogt DP, Bukowski RM, et al. Hepatic artery infusion chemotherapy for colorectal liver metastases. Cleve Clin J Med 1990;57:692-696.
99. Safi F, Bittner R, Roscher R, et al. Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial. Cancer 1989;64:379-387.
100. Schlag P, Hohenberger P, Holting T, et al. Hepatic arterial infusion (HAI) chemotherapy for liver metastases of colorectal cancer using 5-FU. Eur J Surg Oncol 1990;16:99-104.
101. Seitz JF, Perrier H, Giovannini M, et al. 5-Fluorouracil, high-dose folinic acid and mitomycin C combination chemotherapy in previously treated patients with advanced colorectal carcinoma. J Chemother 1998;10:258-265.
102. Shepard KV, Levin B, Karl RC, et al. Therapy for metastatic colorectal cancerwith hepatic artery infusion chemotherapy using a subcutaneous implanted pump. J Clin Oncol 1985;3:161-169.
103. Stagg RJ, Venook AP, Chase JL, et al. Alternating hepatic intra-arterial floxuridine and fluorouracil: a less toxic regimen for treatment of liver metastases from colorectal cancer. J Natl Cancer Inst 1991;83:423-428.
104. Stubbs RS, Alwan MH, Booth MW. Hepatic cryotherapy and subsequent hepatic arterial chemotherapy for colorectal metastases to the liver. HPB Surg 1998;11:97-104.
105. Sugihara K. Continuous hepatic arterial infusion of 5-fluorouracil for unresectable colorectal liver metastases: phase II study. Surgery 1995;117:624-628.
106. Theodors A, Bukowski RM, Lavery I, et al. Hepatic artery infusion with 5-fluorouracil and mitomycin-C in metastatic colorectal carcinoma phase II study. Med Pediatr Oncol 1982;10:463-470.
107. Tono T, Hasuike Y, Ohzato H, et al. Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: A randomized study. Cancer 2000;88:1549-1556.
108. Tucker WG. Treatment of metastatic adenocarcinoma from colon to liver by intra- arterial infusion of chemotherapeutic agents. Panminerva Med 1975;17:299-3304.
109. Valeri A, Mini E, Tonelli P, et al. Intra-arterial hepatic chemotherapy with 5-fluorouracil and 5-methyltetrahydrofolate in the treatment of unresectable liver metastases from colorectal cancer. Anticancer Res 1994;14:2215-2219.
110. van Riel JM, van Groeningen CJ, Albers SH, et al. Hepatic arterial 5-fluorouracil in patients with liver metastases of colorectal cancer: single-centre experience in 145 patients. Ann Oncol 2000;11:1563-1570.
111. Wacker FK, Boese-Landgraf J, Wagner A, et al. Minimally invasive catheter implantation for regional chemotherapy of the liver: a new percutaneous transsubclavian approach. Cardiovasc Intervent Radiol 1997;20:128-132.
112. Wagman LD, Kemeny MM, Leong L, et al. A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol 1990;8:1885-1893.
113. Warren HW, Anderson JH, O'Gorman P, et al. A phase II study of regional 5-fluorouracil infusion with intravenous folinic acid for colorectal liver metastases. Br J Cancer 1994;70:677-680.
114. Wiley AL, Jr., Wirtanen GW, Stephenson JA, et al. Combined hepatic artery 5-fluorouracil and irradiation of liver metastases. A randomized study. Cancer 1989;64:1783-1789.
115. Wils J, Schlangen J, Naus A. Phase II study of hepatic artery infusion with 5-fluorouracil, adriamycin, and mitomycin C (FAM) in liver metastases from colorectal carcinoma. Recent Results Cancer Res 1986;100:157-162.
116. Winton TL, Ghent WR. Hepatic artery infusion chemotherapy with the Infusaid pump: a Canadian experience. Can J Surg 1986;29:379-380.
117. Ensminger WD, Gyves JW. Clinical pharmacology of hepatic arterial chemotherapy. Semin Oncol 1983;10:176-182.
118. Sigurdson ER, Ridge JA, Daly JM. Fluorodeoxyuridine uptake by human colorectal hepatic metastases after hepatic artery infusion. Surgery 1986100:285-291.
119. Alexander HR, Allegra CJ, Lawrence TS. Metastatic Cancer to the Liver, in CANCER Principles & Practice of Oncology, 6th ed., DeVita VT, Hellman S, Rosenberg SA (eds), Lippincott Williams & Wilkins, Philadelphia, PA, 2001, pp. 2697-2702.
120. Kemeny NE, Ron IG. Hepatic arterial chemotherapy in metastatic colorectal patients. Semin Oncol 1999;26:524-535.
121. Kemeny MM, Battifora H, Blayney DW, et al. Sclerosing cholangitis after continuous hepatic artery infusion of FUDR. Ann Surg 1985;202:176-181.
122. Hrushesky WJ, von Roemeling R, Lanning RM, et al. Circadian-shaped infusions of floxuridine for progressive metastatic renal cell carcinoma. J Clin Oncol 1990;8:1504-1513.
123. Curley SA, Hohn DC, Roh MS. Hepatic artery infusion pumps: cannulation techniques and other surgical considerations. Langenbecks Arch Chir 1990;375:119-124.
124. Campbell KA, Burns RC, Sitzmann JV, et al. Regional chemotherapy devices: effect of experience and anatomy on complications. J Clin Oncol 1993;11:822-826.
125. Ansfield FJ, Ramirez G. The clinical results of 5-fluorouracil intrahepatic arterial infusion in 528 patients with metastatic cancer to the liver. Prog Clin Cancer 1978;7:201-206.